Gabapentin in postamputation phantom limb pain: A randomized, double-blind, placebo-controlled, cross-over study

被引:160
作者
Bone, M
Critchley, P
Buggy, DJ
机构
[1] Univ Coll Dublin, Dept Anaesthesia, Mater Misericordiae Hosp, Dublin 7, Ireland
[2] Leicester Gen Hosp, Univ Hosp Leicester, NHS Trust, Dept Anaesthesia & Pain Management, Leicester, Leics, England
[3] Leicester Gen Hosp, Univ Hosp Leicester, NHS Trust, Dept Anaesthesia & Pain Management, Leicester, Leics, England
[4] Leicester Gen Hosp, Univ Hosp Leicester, NHS Trust, Dept Neurol, Leicester, Leics, England
关键词
neuropathic pain; phantom limb pain; anticonvulsants; gabapentin;
D O I
10.1053/rapm.2002.35169
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background and Objectives: Severe phantom limb pain after surgical amputation affects 50% to 67% of patients and is difficult to treat. Gabapentin is effective in several syndromes of neuropathic pain. Therefore, we evaluated its analgesic efficacy in phantom limb pain. Methods: Patients attending a multidisciplinary pain clinic with phantom limb pain were enrolled into this randomized, double-blind, placebo-controlled, cross-over study. Other anticonvulsant therapy was discontinued. Each treatment was 6 weeks separated by a 1-week washout period. Codeine/paracetamol was allowed as rescue analgesia. The daily dose of gabapentin was titrated in increments of 300 mg to 2,400 mg or the maximum tolerated dose. Patients were assessed at weekly intervals. The primary outcome measure was visual analog scale (VAS) pain intensity difference (PID) compared with baseline at the end of each treatment. Secondary measures were indices of sleep interference, depression (Hospital Anxiety and Depression [HAD] scale), and activities of daily living (Bartel Index). Results: Nineteen eligible patients (mean age, 56 years; range, 24 to 68 years; 16 men) were randomized, of whom 14 completed both arms of the study. Both placebo and gabapentin treatments resulted in reduced VAS scores compared with baseline. PID was significantly greater than placebo for gabapentin therapy at the end of the treatment (3.2 +/- 2.1 v 1.6 +/- 0.7, P = .03). There were no significant differences between placebo and gabapentin therapy in terms of the number of tablets of rescue medication required, sleep interference, HAD scale, or Bartel Index. The medication was well tolerated with few reports of adverse effects. Conclusions: After 6 weeks, gabapentin monotherapy was better than placebo in relieving postamputation phantom limb pain. There were no significant differences in mood, sleep interference, or activities of daily living, but a type II error cannot be excluded for these variables.
引用
收藏
页码:481 / 486
页数:6
相关论文
共 22 条
[1]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[2]  
BROWN JP, 1996, REV CONTEMP PHARMACO, V7, P203
[3]   Normative data for the HADS from a large non-clinical sample [J].
Crawford, JR ;
Henry, JD ;
Crombie, C ;
Taylor, EP .
BRITISH JOURNAL OF CLINICAL PSYCHOLOGY, 2001, 40 :429-434
[4]   A test-retest reliability study of the Barthel Index, the Rivermead Mobility Index, the Nottingham Extended Activities of Daily Living Scale and the Frenchay Activities Index in stroke patients [J].
Green, J ;
Forster, A ;
Young, J .
DISABILITY AND REHABILITATION, 2001, 23 (15) :670-676
[5]  
Jensen T S, 2000, Prog Brain Res, V129, P493
[6]   PHANTOM LIMB, PHANTOM PAIN AND STUMP PAIN IN AMPUTEES DURING THE 1ST 6 MONTHS FOLLOWING LIMB AMPUTATION [J].
JENSEN, TS ;
KREBS, B ;
NIELSEN, J ;
RASMUSSEN, P .
PAIN, 1983, 17 (03) :243-256
[7]   IMMEDIATE AND LONG-TERM PHANTOM LIMB PAIN IN AMPUTEES - INCIDENCE, CLINICAL CHARACTERISTICS AND RELATIONSHIP TO PRE-AMPUTATION LIMB PAIN [J].
JENSEN, TS ;
KREBS, B ;
NIELSEN, J ;
RASMUSSEN, P .
PAIN, 1985, 21 (03) :267-278
[8]  
KEIICHI O, 1995, ANESTH ANALG, V80, P1030
[9]   Phantom pain and phantom sensations in upper limb amputees: an epidemiological study [J].
Kooijman, CM ;
Dijkstra, PU ;
Geertzen, JHB ;
Elzinga, A ;
van der Schans, CP .
PAIN, 2000, 87 (01) :33-41
[10]   Continuous blockade of both brachial plexus with ropivacaine in phantom pain: a case report [J].
Lierz, P ;
Schroegendorfer, K ;
Choi, S ;
Felleiter, P ;
Kress, HG .
PAIN, 1998, 78 (02) :135-137